A Single Arm Phase II Pilot Study of Low Dose Vemurafenib Plus Rituximab in the Front-Line and Relapsed/Refractory Treatment of Hairy Cell Leukemia
| Autor: | Hermel, David Jacob, Ter-Zakarian, Anna, New, Jacob, Saven, Alan |
|---|---|
| Zdroj: | In Blood 2 November 2023 142 Supplement 1:4413-4413 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|